Skip to main navigation
Telix Pharmaceuticals Limited Logo
  • Overview
  • News
  • Events & Presentations
    • Events
    • Presentations
  • Financials
    • Half-year & Quarterly Results
    • Annual Reports & AGMs
    • ASX Announcements
    • SEC Filings
  • Pipeline
  • Stock
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Board & Management
    • Documents & Charters
    • Sustainability
  • Resources
    • Shareholder Information
    • Investor Resources
    • Email Alerts
    • Contact Us

Investors

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies.

Minimum 15 minutes delayed. Source: LSEG

Show all

Latest Results | Q1 2026

  • Earnings Release

Events

03 Jun 2026 11:40 AM EDT
Jefferies Global Healthcare Conference
02 Jun 2026 9:00 AM EDT
William Blair 46th Annual Growth Stock Conference
30 Apr 2026 9:30 AM AEST
Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach
17 Mar 2026 3:00 PM EDT
HCW @ Home with Telix Pharmaceuticals
10 Mar 2026 9:30 AM AEDT
ProstACT Global Part 1 Results
  • All Events

 

Presentations

William Blair Growth Conference Presentation
  • All Presentations

News

09 Jun 2026
Change in substantial holding
02 Jun 2026
Telix and United Imaging Announce Strategic Theranostics Collaboration
01 Jun 2026
ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026
01 Jun 2026
Notification regarding unquoted securities - TLX
01 Jun 2026
Appendix 3Y Change in Director Interest - C Behrenbruch
  • All News Releases

Subscribe to our Email Alerts

©2026 Telix Pharmaceuticals Limited.

The Telix Pharmaceuticals and the Illuccix name and logo are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. This website is intended for corporate communication and investor relations purposes only and is not intended as promotion or advertising to any audience in any country worldwide.

Privacy Policy. Terms of Use. Cookies Policy. Forward Looking Statements
  • Twitter
  • LinkedIn
  • Facebook
  • YouTube
Search Investors